| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.10. | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 05.10. | KeyBanc raises Lifestance Health stock price target on specialty care growth | 2 | Investing.com | ||
| 15.09. | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | 1 | Investing.com Deutsch | ||
| 11.09. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.09. | LifeStance prices 22.3 million share secondary offering at $12.35 | 2 | Investing.com | ||
| 09.09. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 4 | GlobeNewswire (USA) | ||
| 09.09. | Canaccord raises Lifestance Health stock price target on growth outlook | 1 | Investing.com | ||
| 09.09. | LifeStance stockholders plan to sell 22.3 million shares | 1 | Investing.com | ||
| 10.08. | LifeStance Health gains as Hedgeye adds as new long idea | 1 | Seeking Alpha | ||
| 06.08. | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 9 | Investing.com | ||
| 06.08. | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| 06.08. | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha | ||
| 06.08. | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | 853 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 07.07. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 5 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,075 | +2,78 % | VW und Autobauer im Fokus: DAX vor dem nächsten Schub? Diese Woche wird für Anleger entscheidend | © Foto: Boris Roessler/dpaDer DAX dürfte freundlich in die neue Woche starten. Auch die europäischen Futures liegen im Plus. Doch Öl, Inflation und die beginnende US-Berichtssaison könnten schnell für... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,540 | +0,20 % | CFO-News: Aumovio, Fresenius Medical Care, Verbund | ||
| SIEMENS HEALTHINEERS | 41,450 | +1,47 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,760 | +0,06 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Carl Zeiss Meditec vor Zahlen auf "Hold" mit einem Kursziel von 26 Euro belassen. Das Medizintechnik-Unternehmen dürfte ein... ► Artikel lesen | |
| TELADOC HEALTH | 5,168 | +2,34 % | Teladoc Health, Inc.: Teladoc Health to Announce Third Quarter 2026 Financial Results | ||
| EUROFINS SCIENTIFIC | 77,74 | +0,05 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 39,245 | -0,63 % | Boston Scientific Names Fitzgerald Executive Vice President & COO In New Operating Restructure | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX), a medical technology company, on Wednesday announced that it has appointed Joseph M. Fitzgerald as Executive Vice President and Chief Operating... ► Artikel lesen | |
| DEXCOM | 76,60 | 0,00 % | DexCom gains as NEJM publication boosts Medicare coverage hopes | ||
| ALIGN TECHNOLOGY | 131,75 | +0,50 % | This Align Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday | ||
| INMODE | 12,585 | +0,28 % | InMode expects Q3 revenue between $91.8M and $92M | ||
| PETMED EXPRESS | 1,137 | +6,96 % | PetMed Express, Inc.: PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director | DELRAY BEACH, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Tamar Elkeles, PhD as a... ► Artikel lesen | |
| TANDEM DIABETES | 15,100 | +4,14 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| INSULET | 122,55 | -2,39 % | Insulet's Omnipod Discover data platform begins full US rollout | ||
| ORGANON | 12,225 | -0,12 % | Organon presents 6-year data for hormone-free IUD MIUDELLA | ||
| MOLINA HEALTHCARE | 184,15 | -0,19 % | Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3? |